NO20000519L - 2-acylaminopropanaminer som takykininreseptorantagonister - Google Patents
2-acylaminopropanaminer som takykininreseptorantagonisterInfo
- Publication number
- NO20000519L NO20000519L NO20000519A NO20000519A NO20000519L NO 20000519 L NO20000519 L NO 20000519L NO 20000519 A NO20000519 A NO 20000519A NO 20000519 A NO20000519 A NO 20000519A NO 20000519 L NO20000519 L NO 20000519L
- Authority
- NO
- Norway
- Prior art keywords
- receptor antagonists
- acylaminopropanamines
- tachykinin receptor
- tachykinin
- acylaminopropanamine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5499797P | 1997-08-06 | 1997-08-06 | |
| PCT/US1998/016333 WO1999007677A1 (en) | 1997-08-06 | 1998-08-06 | 2-acylaminopropanamines as tachykinin receptor antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20000519D0 NO20000519D0 (no) | 2000-02-01 |
| NO20000519L true NO20000519L (no) | 2000-03-31 |
Family
ID=21994906
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20000519A NO20000519L (no) | 1997-08-06 | 2000-02-01 | 2-acylaminopropanaminer som takykininreseptorantagonister |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6358994B1 (zh) |
| EP (1) | EP1005454A4 (zh) |
| JP (1) | JP2001512715A (zh) |
| KR (1) | KR20010022581A (zh) |
| CN (1) | CN1272842A (zh) |
| AU (1) | AU8693398A (zh) |
| BR (1) | BR9811821A (zh) |
| CA (1) | CA2298701A1 (zh) |
| EA (1) | EA200000198A1 (zh) |
| HR (1) | HRP20000065A2 (zh) |
| HU (1) | HUP0002929A3 (zh) |
| ID (1) | ID24468A (zh) |
| IL (1) | IL134301A0 (zh) |
| NO (1) | NO20000519L (zh) |
| PL (1) | PL338453A1 (zh) |
| TR (1) | TR200000291T2 (zh) |
| WO (1) | WO1999007677A1 (zh) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999007681A1 (en) * | 1997-08-06 | 1999-02-18 | Eli Lilly And Company | 2-acylaminopropanamines as tachykinin receptor antagonists |
| PT1385577E (pt) * | 2001-04-23 | 2006-08-31 | Hoffmann La Roche | Utilizacao de antagonistas do receptor nk-1 contra a hiperplasia prostatica benigna |
| DK1501808T3 (da) * | 2002-04-26 | 2008-10-13 | Lilly Co Eli | Tachykininreceptor-antagonister |
| MXPA04010622A (es) | 2002-04-26 | 2005-01-25 | Lilly Co Eli | Derivados de triazol como antagonistas de receptor de taquicinina. |
| AR050253A1 (es) | 2004-06-24 | 2006-10-11 | Smithkline Beecham Corp | Compuesto derivado de indazol carboxamida, composicion que lo comprende y su uso para la preparacion de un medicamento |
| TWI380973B (zh) * | 2005-06-30 | 2013-01-01 | Smithkline Beecham Corp | 化合物 |
| US8063071B2 (en) | 2007-10-31 | 2011-11-22 | GlaxoSmithKline, LLC | Chemical compounds |
| EP2117538A1 (en) | 2007-01-24 | 2009-11-18 | Glaxo Group Limited | Pharmaceutical compositions comprising 2-methoxy-5- (5-trifluoromethyl-tetrazol-i-yl-benzyl) - (2s-phenyl-piperidin-3s-yl-) |
| PE20081889A1 (es) | 2007-03-23 | 2009-03-05 | Smithkline Beecham Corp | Indol carboxamidas como inhibidores de ikk2 |
| EP2406249A1 (en) | 2009-03-10 | 2012-01-18 | Glaxo Group Limited | Indole derivatives as ikk2 inhibitors |
| WO2011104307A2 (en) * | 2010-02-25 | 2011-09-01 | Graffinity Pharmaceuticals Gmbh | Ligands for antibody purification by affinity chromatography |
| CN105906608B (zh) * | 2016-05-03 | 2018-10-19 | 中山大学 | 8-氨基喹啉-松果体素杂联体及其药物组合物 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1340588C (en) | 1988-06-13 | 1999-06-08 | Balraj Krishan Handa | Amino acid derivatives |
| US5278316A (en) * | 1989-06-29 | 1994-01-11 | Warner-Lambert Company | N-substituted cycloalkyl and polycycloalkyl alpha-substituted Trp-Phe- and phenethylamine derivatives |
| DK0533280T4 (da) | 1991-09-20 | 2005-02-28 | Glaxo Group Ltd | Ny medicinsk anvendelse af tachykininantagonister |
| US5328927A (en) | 1992-03-03 | 1994-07-12 | Merck Sharpe & Dohme, Ltd. | Hetercyclic compounds, processes for their preparation and pharmaceutical compositions containing them |
| US5612336A (en) * | 1992-07-13 | 1997-03-18 | Merck, Sharp & Dohme Ltd. | Heterocyclic amide derivatives as tachykinin antagonists |
| ES2153841T3 (es) * | 1992-08-13 | 2001-03-16 | Warner Lambert Co | Antagonistas de la taciquinina. |
| AU5342894A (en) | 1992-10-30 | 1994-05-24 | Merck Sharp & Dohme Limited | Tachykinin antagonists |
| US6403577B1 (en) | 1993-11-17 | 2002-06-11 | Eli Lilly And Company | Hexamethyleneiminyl tachykinin receptor antagonists |
| US5491140A (en) | 1994-06-30 | 1996-02-13 | Eli Lilly And Company | Naphthyl tachykinin receptor antagonists to treat physiological conditions |
| HUT77948A (hu) * | 1994-07-12 | 1998-12-28 | Eli Lilly And Co., | Heterociklusos tachikinin-receptor antagonisták |
-
1998
- 1998-08-06 CA CA002298701A patent/CA2298701A1/en not_active Abandoned
- 1998-08-06 ID IDW20000220A patent/ID24468A/id unknown
- 1998-08-06 EP EP98938403A patent/EP1005454A4/en not_active Withdrawn
- 1998-08-06 WO PCT/US1998/016333 patent/WO1999007677A1/en not_active Application Discontinuation
- 1998-08-06 AU AU86933/98A patent/AU8693398A/en not_active Abandoned
- 1998-08-06 JP JP2000506181A patent/JP2001512715A/ja not_active Withdrawn
- 1998-08-06 HU HU0002929A patent/HUP0002929A3/hu unknown
- 1998-08-06 TR TR2000/00291T patent/TR200000291T2/xx unknown
- 1998-08-06 BR BR9811821-8A patent/BR9811821A/pt not_active Application Discontinuation
- 1998-08-06 EA EA200000198A patent/EA200000198A1/ru unknown
- 1998-08-06 IL IL13430198A patent/IL134301A0/xx unknown
- 1998-08-06 PL PL98338453A patent/PL338453A1/xx unknown
- 1998-08-06 KR KR1020007001172A patent/KR20010022581A/ko not_active Application Discontinuation
- 1998-08-06 CN CN98809800A patent/CN1272842A/zh active Pending
- 1998-08-06 US US09/463,855 patent/US6358994B1/en not_active Expired - Fee Related
-
2000
- 2000-02-01 NO NO20000519A patent/NO20000519L/no not_active Application Discontinuation
- 2000-02-04 HR HR20000065A patent/HRP20000065A2/hr not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL134301A0 (en) | 2001-04-30 |
| WO1999007677A1 (en) | 1999-02-18 |
| BR9811821A (pt) | 2000-08-15 |
| KR20010022581A (ko) | 2001-03-26 |
| HRP20000065A2 (en) | 2001-04-30 |
| PL338453A1 (en) | 2000-11-06 |
| HUP0002929A3 (en) | 2002-01-28 |
| HUP0002929A2 (hu) | 2001-10-28 |
| JP2001512715A (ja) | 2001-08-28 |
| ID24468A (id) | 2000-07-20 |
| NO20000519D0 (no) | 2000-02-01 |
| TR200000291T2 (tr) | 2000-07-21 |
| CN1272842A (zh) | 2000-11-08 |
| EP1005454A1 (en) | 2000-06-07 |
| EA200000198A1 (ru) | 2000-10-30 |
| EP1005454A4 (en) | 2003-01-15 |
| US6358994B1 (en) | 2002-03-19 |
| CA2298701A1 (en) | 1999-02-18 |
| AU8693398A (en) | 1999-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ITRM960810A0 (it) | Composizioni farmaceutiche contenenti ciclosporine o macrolidi | |
| NO20004803L (no) | Smilagening og anzurogenin for behandling av Alzheimers sykdom | |
| DZ2494A1 (fr) | Composition pharmaceutique d'oméprazole. | |
| ID28003A (id) | Turunan-turunan adamantana | |
| MY118151A (en) | Pharmaceutical formulations containing voriconazole. | |
| DZ3191A1 (fr) | Composés d'indazole et compositions pharmaceutiques inhibant les protéines kinases, et procédés d'utilisation de ceux-ci. | |
| NO965377D0 (no) | Indolinonforbindelser samt farmasöytiske preparater inneholdende forbindelsene | |
| NO972451L (no) | Heterosyklyloksy- og tiometyl-1,2,5-tiadiazolidin-3-on 1,1-dioksyder og preparater og fremgangsmåte for anvendelse derav | |
| DE60209929D1 (de) | Succinate des 5,8,14-triazatetracycloä10.3.1.0 2,11 .0 4,9 ü-hexadeca-2(11),3,5,7,9,-pentaens und pharmazeutische zusammensetzungen | |
| EE200100179A (et) | Farmatseutilised agendid Parkinsoni tõve, ADHD jamikroadenoomide raviks | |
| NO972391D0 (no) | 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav | |
| NO20000519L (no) | 2-acylaminopropanaminer som takykininreseptorantagonister | |
| DK1071433T3 (da) | 2',2'-difluornucleosider til immunosuppressiv behandling og kombinationspræparater | |
| DE69907926D1 (de) | 1,2,4-triazol-3-thion verbindungen | |
| NO971997D0 (no) | Bruk av immunmodulerende midler | |
| DE69120287D1 (en) | Aminosulfonylharnstoff-acat-inhibitoren | |
| TR200000455T2 (tr) | Alzheimer hastalığının tedavisinde fankinonun kullanılması. | |
| TR200000697T2 (tr) | İkame edilmiş 1,2,3,4,5,6-Heksahidro-2,6-Metano-3-Benzazosin-10-OL'ler, üretim yöntemleri ve farmasötik preparat olarak kullanımları. | |
| MX9708394A (es) | Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion. | |
| ZA962715B (en) | Pharmaceutical agents for the treatment of Alzheimer's disease. | |
| HUP9900863A3 (en) | 4,4-(disubstituted)cyclohexan-1-ol derivatives pharmaceutical compositions containing these compounds and use thereof | |
| TR199901385T2 (xx) | Piperidin t�revleri. | |
| NZ505085A (en) | Pharmaceutical compositions comprising bipapcitide monocarboxylate and/or bipapcitide dicarboxylate for imaging and treating thrombi | |
| DE69614552T2 (de) | MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE | |
| TR200000916T2 (tr) | İkameli piperidin türevleri. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |